Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P457: Complications and disease recurrence after primary ileocecal resection in paediatric Crohn’s disease: a multicentre cohort analysisECCO '16 Amsterdam
Year: 2016
Authors:

K. Diederen*1, L. de Ridder2, P. van Rheenen3, V. Wolters4, L. Mearin5, G. Damen6, T. de Meij7, H. van Wering8, L. Tseng1, M. Oomen9, J. de Jong9, M. Benninga1, A. Kindermann1

1Academic Medical Centre, Department of Paediatric Gastroenterology and Nutrition, Amsterdam, Netherlands, 2Erasmus MC-Sophia Children’s Hospital, Department of Paediatric Gastroenterology, Rotterdam, Netherlands, 3University Medical Centre Groningen, Department of Paediatric Gastroenterology, Groningen, Netherlands, 4University Medical Centre Utrecht, Department of Paediatric Gastroenterology, Utrecht, Netherlands, 5Leids Universitair Medisch Centrum, Department of Paediatrics, Leiden, Netherlands, 6Radboud University Medical Centre, Department of Paediatric Gastroenterology, Nijmegen, Netherlands, 7VU University Medical Centre, Department of Paediatric Gastroenterology, Amsterdam, Netherlands, 8Amphia Hospital, Department of Paediatrics, Breda, Netherlands, 9Academic Medical Centre, Department of Paediatric Surgery, Amsterdam, Netherlands

P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD auditECCO '16 Amsterdam
Year: 2016
Authors:

A. St. Clair Jones*1, S. Murray2

1Brighton and Sussex University Hospitals NHS Trust, Pharmacy, Brighton, United Kingdom, 2Royal College of Physicians, Clinical Effectiveness and Evaluation Unit, London, United Kingdom

P459: Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remissionECCO '16 Amsterdam
Year: 2016
Authors:

M. Iborra*1, B. Navarro1, X. Cortes2, M. Boscá3, T. Blazquez1, J. Herreras1, G. Trejo3, B. Beltrán1, P. Nos1

1Hospital Universitari i Politecnic La Fe, Gastroenterology, Valencia, Spain, 2Hospital de Sagunto, Gastroenterology, Sagunto, Spain, 3Hospital Clínic Valencia, Gastroenterology, Valencia, Spain

P460: Effect of fertility treatment on inflammatory bowel disease outcomesECCO '16 Amsterdam
Year: 2016
Authors:

M. Bejaoui*, C. Landman, J. Kirchgesner, A. Bourrier, I. Nion-Larmurier, H. Sokol, L. Beaugerie, J. Cosnes, P. Seksik

Saint Antoine Hospital, Gastroenterology & Nutrition, Paris, France

P461: Clinical benefit of adalimumab after surgery in the treatment of complex perianal Crohn’s disease: a tertiary referral centre experienceECCO '16 Amsterdam
Year: 2016
Authors:

G. Solina*1, S. Renna2, E. Orlando2, M. Affronti2, M. Cottone2, A. Orlando2

1’Villa Sofia-V. Cervello’ Hospital, Division of Surgery, Palermo, Italy, 2’Villa Sofia-Cervello’ Hospital, Division of Internal Medicine, Palermo, Italy

P462: Adalimumab improves treatment satisfaction with medication and work productivity amongst patients with ulcerative colitis in a clinical practice setting: results from INSPIRADAECCO '16 Amsterdam
Year: 2016
Authors:

S. Travis*1, B. Feagan2, L. Peyrin-Biroulet3, R. Panaccione4, S. Danese5, A. Lazar6, A. Robinson7, J. Petersson7, M. Bereswill6, M. Skup7, N. Chen7, S. Wang7, R. Thakkar7, J. Chao7

1Oxford University Hospitals, Oxford, United Kingdom, 2Robarts Research Institute, Ontario, Canada, 3University Hospital of Nancy, Les Nancy, France, 4University of Calgary, Medicine, Calgary, Canada, 5Istituto Clinico Humanitas, Milan, Italy, 6AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany, 7AbbVie Inc, North Chicago, Illinois, United States

P463: Combination therapy of fresh faecal microbial transplantation and antibiotics for ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

D. Ishikawa*, T. Osada, K. Haga, T. Kodani, T. Shibuya, S. Watanabe

Juntendo University, Department of Gastroenterology, Tokyo, Japan

P464: Assessing medication adherence in patients with inflammatory bowel disease: what do we choose, self-adherence scales or pharmacy rates?ECCO '16 Amsterdam
Year: 2016
Authors:

M. L. De Castro*1, L. Sanromán1, A. Martín2, N. Martínez2, M. Figueira1, V. Hernández1, J. R. Pineda1, J. Martínez-Cadilla1, S. Pereira1, V. Del Campo3, J.-I. Rodríguez-Prada1

1Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo. CHUVI, Gastroenterology, Vigo, Spain, 2Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo. CHUVI, Hospital Pharmacy, Vigo, Spain, 3Hospital Alvaro Cunqueiro. Complexo Hospitalario Universitario de Vigo. CHUVI, Epidemiology, Vigo, Spain

P465: Indication-specific feasibility assessment of a placebo-controlled randomised mesalazine withdrawal study for paediatric patients with ulcerative colitisECCO '16 Amsterdam
Year: 2016
Authors:

N. Croft1, W. Faubion2, D. Tierens3, J. Dewulf3, D. Bwirire3, D. Stefani-Hunyady4, F. Cataldi*5

1Blizard Institute, Barts and The London School of Medicine and Dentistry, Centre for Immunobiology, London, United Kingdom, 2Mayo Clinic, Department of Gastroenterology and Hepatology, Rochester, Minnesota, United States, 3Shire, Brussels, Belgium, 4Shire, Lexington, Massachusetts, United States, 5Shire, Gastroenterology, Lexington, Massachusetts, United States

P466: Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumour necrosis factor alpha therapy: a prospective single-centre open-label studyECCO '16 Amsterdam
Year: 2016
Authors:

T. Hlavaty*, A. Krajcovicova, J. Letkovsky, I. Sturdik, T. Koller, J. Toth, M. Huorka

Comenius University, Faculty of Medicine and University Hospital Bratislava, Fifth Department of Internal Medicine, Bratislava, Slovakia

P467: The validation of the Crohn’s and Ulcerative Colitis Questionnaire–12 Plus (CUCQ-12 plus): a short quality-of-life measure for inflammatory bowel diseaseECCO '16 Amsterdam
Year: 2016
Authors:

S. Shwana*1, L. Alrubaiy1, H. Hutchings2, J. Williams2, A. Protheroe3, K. Mortier4

1Prince Charles Hospital, Gastroenterology, Merthyr Tydfil, United Kingdom, 2College of Medicine, Swansea University, Swansea, United Kingdom, 3Royal College of Physicians,, London, United Kingdom, 4Royal College of Physicians, London, United Arab Emirates

P468: Long-term efficacy and safety of thiopurine in biologic-naïve Japanese patients with ulcerative colitis: a multicentre retrospective studyECCO '16 Amsterdam
Year: 2016
Authors:

T. Takagi*1, M. Matsuura2, S. Yamada2, S. Bamba3, Y. Hotta1, K. Uchiyama1, Y. Naito1, H. Nakase2, A. Andoh3, T. Kawamura4, S. Katsushima5, T. Kusaka6, H. Obata7, T. Kogawa8

1Kyoto Prefectural University of Medicine, Molecular Gastroenterology and Hepatology, Kyoto, Japan, 2Kyoto University Hospital, Department of Gastroenterology and Hepatology, Kyoto, Japan, 3Shiga University of Medical Science, Department of Medicine, Otsu, Japan, 4Kyoto Second Red Cross Hospital, Kyoto, Japan, 5National Hospital Organisation Kyoto Medical Centre, Kyoto, Japan, 6Kyoto Katsura Hospital, Kyoto, Japan, 7Obata Medical Clinic, Kyoto, Japan, 8Kogawa Internal Medicine Clinic, Internal Medicine Clinic, Kyoto, Japan

P469: Changes in peripheral blood lymphocyte subsets induced by azathioprine in Crohn’s disease patientsECCO '16 Amsterdam
Year: 2016
Authors:

A. Labidi*, M. Fekih, N. Ben Mustapha, S. Ben Amor, M. Serghini, L. Kallel, J. Boubaker, A. Filali

La Rabta University Hospital, Gastroenterology, Tunis, Tunisia

P470: Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn’s diseaseECCO '16 Amsterdam
Year: 2016
Authors:

P. Pavlidis*, G. Chung- Faye, P. Dubois, I. Bjarnason, B. H. Hayee

King’s College Hospital, Department of Gastroenterology, London, United Kingdom

P471: Safety analysis of multimatrix mesalazine amongst patients with ulcerative colitis or recurrent diverticulitis ≥ 55 years of ageECCO '16 Amsterdam
Year: 2016
Authors:

G. Lichtenstein1, K. Barrett2, D. Stefani-Hunyady3, F. Cataldi*4, J. Raskin5

1University of Pennsylvania Healthy System, Inflammatory Bowel Disease Centre, Philadelphia, Pennsylvania, United States, 2Shire, Basingstoke, United Kingdom, 3Shire, Lexington, Massachusetts, United States, 4Shire, Gastroenterology, Lexington, Massachusetts, United States, 5University of Miami Health System, Gastroenterology and Internal Medicine, Miami, Florida, United States

P472: Faecal calprotectin as a biomarker of early mucosal healing in patients with ulcerative colitis naïve to adalimumab treatmentECCO '16 Amsterdam
Year: 2016
Authors:

C. Muñoz Villafranca*1, A. Perez de Arenaza2, L. Gómez3, R. Higuera4, A. Munagorri5, M. A. Ogueta6, S. Ibañez7, J. Ortiz de Zárate8, O. Merino3, C. Rodriguez9, O. Nante9, P. Arreba10, P. Ramirez de la Piscina11, I. Rodríguez12, A. Bernal13, J. A. Arévalo13, J. L. Cabriada13

1Hospital Universitario de Basurto, Aparato Digestivo, Bilbao, Spain, 2Hospital Universitario de Basurto, Bilbao, Spain, 3Hospital Universitario de Cruces, Gastroenterology, Baracaldo, Spain, 4Hospital San Eloy, Gastroenterology, Baracaldo, Spain, 5Hospital Donostia, Gastroenterology, Donosti, Spain, 6Hospital de Santiago, Gastroenterology, Vitoria, Spain, 7Hospital Universitario de Cruces, Gastroenterology, Baracaldo, Spain, 8Hospital Universitario de Basurto, Gastroenterology, Bilbao, Spain, 9Hospital de Navarra, Gastroenterology, Pamplona, Spain, 10Hospital Universitario de Basurto, Gastroenterology, Bilbao, Spain, 11Hospital de Txagorritxu, Gastroenterology, Vitoria, Spain, 12Hospital de Galdakao, Galdakao, Spain, 13Hospital de Galdácano, Gastroenterology, Galdácano, Spain

P473: Clinical and biochemical factors that influence response in inflammatory disease patients receiving tacrolimusECCO '16 Amsterdam
Year: 2016
Authors:

I. Rodríguez - Lago*1, 2, O. Merino2, 3, O. Nantes2, 4, C. Muñoz2, 5, U. Aguirre6, J. L. Cabriada1, 2

1Galdakao Hospital, Gastroenterology, Galdakao, Spain, 2IBD Study Group of the Basque – Navarre Society of Gastrointestinal Diseases, Pais Vasco - Navarra, Spain, 3Cruces University Hospital, Gastroenterology, Bilbao, Spain, 4Complejo Hospitalario de Navarra, Gastroenterology Department, Pamplona, Spain, 5Basurto University Hospital, Gastroenterology, Bilbao, Spain, 6Galdakao Hospital, Research Unit, Galdakao, Spain

P474: Assessing the position of systemic tacrolimus in the treatment of inflammatory bowel disease: systematic review and meta-analysisECCO '16 Amsterdam
Year: 2016
Authors:

M. Lie*, J. Kreijne, B. Hansen, J. van der Woude

Erasmus MC, Gastroenterology and Hepatology, Rotterdam, Netherlands

P475: Gastroenterological and reumatological chronic patients: are there differences in individual welfare and quality of life?—a cross-observational studyECCO '16 Amsterdam
Year: 2016
Authors:

A. Stefani, M. G. Vettorato*, G. Lorenzon, T. Marcon, F. Simonetti, A. Rigo, E. V. Savarino, E. De Marchi, R. D’Incà, G. C. Sturniolo

University of Padua, Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy, Padua, Italy

P476: Fermentable carbohydrates (FODMAPs) as triggers of functional gastrointestinal symptoms in patients with quiescent inflammatory bowel disease: a double-blind, placebo-controlled, randomised, cross-over re-challenge trialECCO '16 Amsterdam
Year: 2016
Authors:

S. Cox*1, A. Prince1, 2, C. Myers1, 3, P. M. Irving1, 4, J. O. Lindsay5, M. C. Lomer1, 4, K. Whelan1

1King’s College London, School of Medicine, Diabetes and Nutritional Sciences Division, London, United Kingdom, 2King’s College Hospital NHS Foundation Trust, Nutrition and Dietetics, London, United Kingdom, 3The Royal Surrey County Hospital NHS Trust, Nutrition and Dietetics, Guildford, United Kingdom, 4Guy’s and St Thomas’ NHS Foundation Trust, Gastroenterology, London, United Kingdom, 5Barts Health NHS Trust, Gastroenterology, London, United Kingdom